543 related articles for article (PubMed ID: 29871485)
1. Polydopamine Nanoparticles Enhance Drug Release for Combined Photodynamic and Photothermal Therapy.
Poinard B; Neo SZY; Yeo ELL; Heng HPS; Neoh KG; Kah JCY
ACS Appl Mater Interfaces; 2018 Jun; 10(25):21125-21136. PubMed ID: 29871485
[TBL] [Abstract][Full Text] [Related]
2. Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy.
Zhang D; Wu M; Zeng Y; Wu L; Wang Q; Han X; Liu X; Liu J
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8176-87. PubMed ID: 25837008
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
[TBL] [Abstract][Full Text] [Related]
4. Chlorin e6 and polydopamine modified gold nanoflowers for combined photothermal and photodynamic therapy.
Wu F; Liu Y; Wu Y; Song D; Qian J; Zhu B
J Mater Chem B; 2020 Mar; 8(10):2128-2138. PubMed ID: 32073096
[TBL] [Abstract][Full Text] [Related]
5. A Trojan horse biomimetic delivery strategy using mesenchymal stem cells for PDT/PTT therapy against lung melanoma metastasis.
Ouyang X; Wang X; Kraatz HB; Ahmadi S; Gao J; Lv Y; Sun X; Huang Y
Biomater Sci; 2020 Feb; 8(4):1160-1170. PubMed ID: 31848537
[TBL] [Abstract][Full Text] [Related]
6. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Synergistic Photodynamic, Photothermal, Chemodynamic, and Starvation Therapy Performance of Chlorin e6 Immobilized, Polydopamine-Coated Hollow, Porous Ceria-Based, Hypoxia-Tolerant Nanozymes Carrying a Cascade System.
Süngü Akdogan ÇZ; Akbay Çetin E; Onur MA; Önel S; Tuncel A
ACS Appl Bio Mater; 2024 May; 7(5):2781-2793. PubMed ID: 38380497
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate photosensitizer decorated with hyaluronic acid for photodynamic/photothermal cancer targeting therapy.
Wang X; Ouyang X; Chen J; Hu Y; Sun X; Yu Z
Nanomedicine (Lond); 2019 Jan; 14(2):151-167. PubMed ID: 30511886
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of New PEGylated Polydopamine-Based Nanoconstructs Bearing ROS-Responsive Linkers and a Photosensitizer for Bimodal Photothermal and Photodynamic Therapies against Cancer.
Zmerli I; Ibrahim N; Cressey P; Denis S; Makky A
Mol Pharm; 2021 Sep; 18(9):3623-3637. PubMed ID: 34431682
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine Coated PB-MnO
Odda AH; Li H; Kumar N; Ullah N; Khan MI; Wang G; Liang K; Liu T; Pan YY; Xu AW
Bioconjug Chem; 2020 May; 31(5):1474-1485. PubMed ID: 32286806
[TBL] [Abstract][Full Text] [Related]
11. Ce6-Conjugated and polydopamine-coated gold nanostars with enhanced photoacoustic imaging and photothermal/photodynamic therapy to inhibit lung metastasis of breast cancer.
Li Z; Yang F; Wu D; Liu Y; Gao Y; Lian H; Zhang H; Yin Z; Wu A; Zeng L
Nanoscale; 2020 Nov; 12(43):22173-22184. PubMed ID: 33135699
[TBL] [Abstract][Full Text] [Related]
12. Oxidation triggered formation of polydopamine-modified carboxymethyl cellulose hydrogel for anti-recurrence of tumor.
Zhang Y; Zhu C; Zhang Z; Zhao J; Yuan Y; Wang S
Colloids Surf B Biointerfaces; 2021 Nov; 207():112025. PubMed ID: 34403982
[TBL] [Abstract][Full Text] [Related]
13. Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.
Phuong PTT; Lee S; Lee C; Seo B; Park S; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
Colloids Surf B Biointerfaces; 2018 Nov; 171():123-133. PubMed ID: 30025374
[TBL] [Abstract][Full Text] [Related]
14. A Gd-doped polydopamine (PDA)-based theranostic nanoplatform as a strong MR/PA dual-modal imaging agent for PTT/PDT synergistic therapy.
Pu Y; Zhu Y; Qiao Z; Xin N; Chen S; Sun J; Jin R; Nie Y; Fan H
J Mater Chem B; 2021 Feb; 9(7):1846-1857. PubMed ID: 33527969
[TBL] [Abstract][Full Text] [Related]
15. Construction of PEGylated chlorin e6@CuS-Pt theranostic nanoplatforms for nanozymes-enhanced photodynamic-photothermal therapy.
Sheng Y; Ren Q; Tao C; Wen M; Qu P; Yu N; Li M; Chen Z; Xie X
J Colloid Interface Sci; 2023 Sep; 645():122-132. PubMed ID: 37146376
[TBL] [Abstract][Full Text] [Related]
16. Cu
Xiang H; Xue F; Yi T; Tham HP; Liu JG; Zhao Y
ACS Appl Mater Interfaces; 2018 May; 10(19):16344-16351. PubMed ID: 29697957
[TBL] [Abstract][Full Text] [Related]
17. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P
Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355
[TBL] [Abstract][Full Text] [Related]
18. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics.
Dai L; Shen G; Wang Y; Yang P; Wang H; Liu Z
J Mater Chem B; 2021 Jan; 9(4):1151-1161. PubMed ID: 33434248
[TBL] [Abstract][Full Text] [Related]
19. Titania and silica nanoparticles coupled to Chlorin e6 for anti-cancer photodynamic therapy.
Youssef Z; Jouan-Hureaux V; Colombeau L; Arnoux P; Moussaron A; Baros F; Toufaily J; Hamieh T; Roques-Carmes T; Frochot C
Photodiagnosis Photodyn Ther; 2018 Jun; 22():115-126. PubMed ID: 29581041
[TBL] [Abstract][Full Text] [Related]
20. O
Lin T; Zhao X; Zhao S; Yu H; Cao W; Chen W; Wei H; Guo H
Theranostics; 2018; 8(4):990-1004. PubMed ID: 29463995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
